Medicine Notes > Oxford Medicine Notes > Neuroscience 1 Notes

Pain Notes

This is a sample of our (approximately) 17 page long Pain notes, which we sell as part of the Neuroscience 1 Notes collection, a First package written at Oxford in 2015 that contains (approximately) 266 pages of notes across 23 different documents.

Learn more about our Neuroscience 1 Notes

The original file is a 'Word (Docx)' whilst this sample is a 'PDF' representation of said file. This means that the formatting here may have errors. The original document you'll receive on purchase should have more polished formatting.

Pain Revision

The following is a plain text extract of the PDF sample above, taken from our Neuroscience 1 Notes. This text version has had its formatting removed so pay attention to its contents alone rather than its presentation. The version you download will have its original formatting intact and so will be much prettier to look at.

05/01/2016 Nociception Definitions i) Nociception: Detection of tissue damage by specialised transducers connected to A delta and C fibres ii) Pain: Subjective response of the individual to nociceptive input to the brain and may be totally unrelated to the actual physical parameters of intensity and duration of the stimulus Pain: Unpleasant physical or emotional sensation in response to tissue damage or the potential for tissue damage
-Body's way of alerting oneself to danger to prevent further damage , protect the injured part while it heals and withdraw from dangerous situations
-Pain is the most common symptom that patients present to their doctor- so understanding it is crucial to improve the quality of life of patients Classification
-Pain classified - severity, location, duration
-Severity: Pain is highly subjective so difficult to treat- only assessment of intensity of pain is from the patient - rating from 0-10
-How much pain experienced also depends on context (pain beliefs, expectation, placebo), cognitive set (hypervigilance, attention, distraction, catastrophizing), chemical and structure (Neurodegenration, metabolic, maladaptive plastiticty)
-Location of pain- based on body part/ region - visceral pain (organs), deep somatic pain (muscles, fascia), superficial somatic pain (cutaneous/subcutaneous)
-Visceral pain- diffuse and can't be pinpointed to specific location
-Somatic pain is localised and specific
-Duration: Acute pain- specific aetiology, so can be treated easily, Chronic pain (persists for more than 3 months)- back pain, arthritis is often treated symptomatically because it can't be treated as easily Persistent pain: subdivided into Nociceptive and neuropathic, Nociceptive pain results from activation of nociceptors in skin, soft tissue Neuropathic pain: Damge of nerves/ neural tissue itself rather than tissue the nerve is supplying, often burning or electric sensation, syndromes of reflex sympathetic dystrophy, post herpetic neuralgia - MS- not peripheral activation of nociceptors Nociceptors
- Nociception - ability of the body to perceive harmful stimuli in periphery and transmit these signals to the CNS to create experience of pain
-Nociceptors- free nerve endings of primary sensory afferents which have cell bodies in dorsal root/ trigerminal ganglia
-Free nerve endings cover a large area, poor localisation of pain
-3 broad types:

-Thermal- respond to temperature, extreme heat (>45) and extreme cold (50 degrees temperature - like other classes of nociceptors these cells sensitise to both mechanical and thermal stimuli in presence of tissue injury or inflammation
-Type 2 Adelta nociceptors respond to noxious thermal stimuli Preferentially to mechanical stimuli
-C fiber nociceptors- polymodal- larger, unmyelinated slower- populations of neurons responding to either heat, mechanical or cold nociceptive stimuli. Some C fiber nociceptors are sensitive to heat and mechanical stimuli (CMH nociceptors) whereas others are referred to as silent /sleeping nociceptors- develop sensitivity to heat and chemical stimuli in presence of injury or inflammation
-C fibres innervating the viscera are notable in that they respond to non-injurious stimuli such as stretching of hollow organs while those fibers innervating teeth are responsive to nearly any intensity stimulus to elicit sensations of pain
-So when painful stimulus is applied- immediate sharp pain is due to Aδ fibres, persistent feeling that lasts even after the stimulus is removed- C fibres- more diffuse, dull Visceral nociceptors/ Silent nociceptors
-Found in the viscera- not normally activated by noxious stimuli but instead inflammation C fibres- silent/ dormant
-Few nociceptive fibres innervating viscera- show lot of divergence so the pain presented is diffuse
-Threshold for firing is high, but is reduced massively during infllamtory mediators
-Visceral bloating, GIT cramp, appendicitis, cardiac ischaemia
-Afferent fibres transmit visceral sensory information traven in nerves of sympathetic and more commonly parasympathetic system
-Cardiac general visceral sensory pain fibres follow sympathetitcs back to the spinal cord, cell bodies located in thorasic dorsal root of ganglia- so CNS perceives pain from heart coming from somatic portion of body supplied by thoracic spinal cord segments 1-4. Convergence of information from cutaneous pain sensation axons and visceral pain-Heart- left chest, shoulder, upper left arm referred pain
-Fore gut: T5-T9, Epigastric reigon
-Midgut- periumbilical region via lesser planchnic nerves (T10, T11), only when parietal peritoneum (somatic) over appendix doess pain localise over the right iliac fossa

-Hindgut: suprapubic region (T12) via least splanchnic nerves Molecular level of nociceptors Thermal nociceptors
-C fibres exhibit heat evoked membrane currents with a moderate threshold of 45 degrees
-Type 1 Adelta nocicpetors- respond to a high threshold of 55 degrees
-Thermal nociceptors and chemical nociceptors - TRPV1 channel- non selective cation channel- opens at high temperature/ binding of various ligands such as capsaicin (active ingredient in chillies)
-The capsaicin shifts the sensitivity to the TRPV1 channels to a lower temperature
-Depolarisation from this channel opening depolarises the nerve ending and causes sensation of pain due to heat/ due to application of chilli powder Analgesic drugs: can be both agonists and antagonists - capsaicin based creams on market offer pain relief by first causing light burning sensation but lead to desnensitisation of the receptor- so reduce activity of it
-Antagonists of channel: Capsazepine - blocks activity of TRPV channels- so reduces firing rate of these neurons
-variety of TRP channels in nociceptors throught to underlie perception of a wide range of temperatures from extreme cold to intense heat- TRPV2 channel- Aδ Fibre terminals and is activated by very high temperatures, TRPM8- activated by low temperatures and by chemicals-menthol
-There is a debate that TRPA1 detects noxious cold stimuli
-Xenopus oocytes are injected with mRNA encoding transient receptor potential channels. Electrophysiological recordings from oocytes reveal thermosensitivity of channels. Temperature at which a specific TRP channel is activated is shown by downward deflection of recording
-ASICs respond to low pH
-Mas related G protein coupled receptor family- activated by peptide ligands and serve o sensitise nociceptors to other chemicals released in their local environment
-MDEC/ DRASIC/ TREK-1 detect high pressure
-Nociceptors also selectively express tetrodotoxin resistant Na+ channels
-One Na+ channel: SCN9A- key role in perception of pain in humans
-Mutations in SCN9A channel- voltage gated sodium channel which is expressed in high levels in nociceptive neurons- mutations cause production of truncated, dysfunctional channel-so prevent transmission of impulses from the nociceptors
-Very serious condition- children affected by this condition can't feel pain-so are likely to cause permanent damage without relasing

-Second class of mutations in SCN9A gene- Na V 1.7 channel changes the inactivation kinetics of this channel- Paroxysmal extreme pain disorder- rectal, ocular, submandibular pain Sensitivity to pain
-Congenital insensitivity to pain - cause varies
-Excess release of endorphins in the brain which suppress the response to pain
-Physiologically pain is modulated so that in high stress situations- there is some analgesiaE.g athletes/ soldiers don't feel the full extent of their injuries until the battle is over
-Uncontrolled activation of nociceptors- Allodynia + Hyperalgsia
-Hyperalgesia: exaggerated response to noxious stimuli- most people report persistence in the absence of sensory stimulation
-allodynia: feel pain in response to stimuli that are normally innocuous- by a light stroking of sunburned skin, by arthritis Peripheral component of Hyperalgesia- primary hyperalgesia
-Peripheral sensitisation- reduction in threshold+ increase in responsiveness of peripheral ends of nociceptors found at sites of tissue damage and inflammation-- caused by chemicals released from damaged cells that accumulate at site of tissue injury- peptides, proteins such as bradykinin, Substance P, nerve growth factor, ATP, histaminethis may be physiological and temporary- to prevent further injury to an infected/inflamed area below
-E.g change in heat sensitivity after a sunburn-when normally warm stimulus such as a shower feels burning hot in sunburned areas-mechanical thresholds for pain are lowered at sites of burns- also found the mechanical hyperalgesia-larger than area of flare
-Sensitisation-arises due to action of inflammatory mediators a) Bradykinin
-proteolytic cleavage of active kinins from precursor protein in plasma-Bradykinin-occurs following tissue injury-to show that it is a contributor to pain hypersensitivity-injection of bradykinin into human skin produces dose dependent pain and heat hyperalgesia-this shows bradykinin can exite nociceptors and sensitise their response to heat acts by combining with specific GPCR- B1, B2 nociceptive neurons:
- B2 receptors are coupled to activation of PLC(B)-this catalyses breakdown of PIP2 to IP3-this causes rise in Ca2+- release of DAG-this activates- protein kinaes C ε
isoform- this enhances heat activated current through phosphorylates TRPVI and facilitates TRPVI
-Another mechanism involved in bradykinin induced acute sensitisation of TRPV1hydrolysis of PIP2 by PLC- sensitises channel by relieving TRPV1 from PIP2 inhibition
-Bradykinin also is able to activate the TRPV1 channels directly-based on the observation that bradykinin evoked action potentials were reduced by TRPV1 antagonist capsazepine

-As number of bradykinin induced action potentials in C fibres reduced by lipoxygenase inhibitors-suggests the lipoxygenase products may be involved in this process
-Activation of PLA2 induces mobilisation of Arachidonic acid and generation via the lipoxygenase pathway of 12-HPETE-shown to activate TRPV1 directly
-Also acts on B2 receptors- but bradykinin is converted in tissues by removal of terminal arginine residue to des-Arg Bradykinin- selectively acts on B1 receptors. B1 receptors expressed at low levels but up-regulated in inflamed tissues
-Transgenic KO lacking either type of receptor- reduced inflammatory hyperalgesia Prostaglandins:
-Prostaglandins are another inflammatory mediator-produced mainly by the activation of COX-2 enzymes-upregulated during inflammation
-Prostanoid interact with GPCR- three of these receptors sensitise primary afferent fibresprostaglandin E2 receptors EP1 and EP2 and prostaglanding I2/prostacyclin receptor IPinduce phosphorylation of ion channels which show increased sensitivity to other agentsPKC dependent pathway and Camp/PKA signalling cascade
-Phosphorylation promotes the opening of the vanilloid receptors, calcium channels, voltage dependent Na+ channels, closure of K channels-these increase membrane sensitivity to depoalrisatin- so a smaller stimulus is needed to reach threshold
-Prostaglandins also function as 2nd messengers in potentiation of TRPV1 by other inflammatory mediators such as glutamate-contribute to the development of inflammatory hyperalgesia through group 1 metabotropic glutamate receptors
-These receptors are coupled to PLC pathway-activates PKC downstream-the PKC pathway also leads to the activation of cyclooxygenases. PLC generates lipid messengers such as arachidonic acid-COX metabolises enzymes into prostaglandins-this activates the PKA pathway through prostaglandin receptors
-Analgesic effects of NSAIDs- inhibit prostaglandin synthesis-blocking enzyme Cyclooxygenase 2- normally form prostaglandins -aspirin, ibuprofen
-Acetaminophen- analgesic effects- selective inhibition of COX3 ATP:
-Released from damaged tissues- ATP-produces pain by directly activating nociceptors and induces hyperalgesia by sensitisation of nociceptors to other noxious stimuli
-Two types of ATP receptors expressed on nociceptive neurns-ionotropic P2X and metabotropic P2Y receptors
-Acting via - P2X3 receptors- ligand gated ion channel- selectively expressed by these neurons- down regulation of these receptors by antisense DNA technology reduces inflammatory pain
-P2Y play important role in ATP induced sensitation of TRPV1- as in TRPV1 KO mice, extracellular ATP fails to induce thermal hyperalgesia-patch clamp experiments also confirm that extracellular ATP enhance TRPV1 dependent capsaicin and

****************************End Of Sample*****************************

Buy the full version of these notes or essay plans and more in our Neuroscience 1 Notes.